Lalantha Leelarathna

Home Use of an Artificial Beta Cell in Type 1 Diabetes

Hood Thabit, Martin Tauschmann, Janet M. Allen et al. · New England Journal of Medicine · 2015 · 448 citations · Full text

Medicine, Bioengineering, Endocrinology +16

Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial

Martin Tauschmann, Hood Thabit, Lia Bally et al. · The Lancet · 2018 · 437 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice

Moshe Phillip, Revital Nimri, Richard M. Bergenstal et al. · Endocrine Reviews · 2022 · 402 citations · Full text

Medicine, Health Policy, Diabetology +16

A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

David C. Klonoff, Jing Wang, David Rodbard et al. · Journal of Diabetes Science and Technology · 2022 · 276 citations · Full text

Medicine, Endocrinology, Internal Medicine +17

Recovery of Hypoglycemia Awareness in Long-standing Type 1 Diabetes: A Multicenter 2 × 2 Factorial Randomized Controlled Trial Comparing Insulin Pump With Multiple Daily Injections and Continuous With Conventional Glucose Self-monitoring (HypoCOMPaSS)

Stuart Little, Lalantha Leelarathna, Emma Walkinshaw et al. · Diabetes Care · 2014 · 234 citations · Full text

Medicine, Internal Medicine, Diabetology +16